Novartis AG NVS
$ 96.94
0.18%
Annual report 2023
added 12-14-2024
Novartis AG Financial Ratios 2011-2024 | NVS
Annual Financial Ratios Novartis AG
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | 8.1 | 24.6 | 17.2 | 13.0 | 21.4 | 23.0 | 9.4 | 20.7 | 19.1 | 15.5 | 12.7 |
P/S |
- | - | - | 4.0 | 4.1 | 3.1 | 3.3 | 3.1 | 3.3 | 3.9 | 3.0 | 2.6 | 2.0 |
EPS |
- | - | 10.7 | 3.5 | 5.1 | 5.4 | 3.3 | 2.8 | - | - | - | - | - |
EV (Enterprise Value) |
39.8 B | 50.5 B | 247 B | 260 B | 253 B | 217 B | 214 B | 202 B | 222 B | 266 B | 227 B | 203 B | 167 B |
EBITDA per Share |
- | - | 5.21 | 4.46 | 3.97 | 3.62 | 3.71 | 6.02 | 6.01 | 6.5 | 6.49 | 6.8 | 7.05 |
EV/EBITDA |
16.5 | 14.0 | 15.8 | 13.1 | 14.4 | 11.9 | 12.8 | 13.9 | 11.8 | 9.9 | 7.9 | ||
PEG |
- | -20.8 | -6.58 | -2.23 | -1.35 | -2.13 | -0.37 | 0.12 | 1.73 | -4.41 | 5.96 | -1.21 | |
P/B |
- | - | 2.9 | 3.5 | 3.6 | 2.1 | 2.2 | 2.1 | 2.2 | 3.0 | 2.4 | 2.1 | 1.8 |
P/CF |
- | - | 12.9 | 14.5 | 14.8 | 11.5 | 13.0 | 17.9 | 20.0 | 20.2 | 18.2 | 13.3 | 9.7 |
ROE % |
- | - | - | 14.24 | 21.12 | 16.03 | - | 8.97 | 23.08 | 14.43 | 12.34 | 13.76 | 13.84 |
ROA % |
- | - | 18.22 | 6.32 | 9.91 | 8.66 | 5.79 | 5.16 | 13.52 | 8.14 | 7.27 | 7.65 | 7.76 |
ROCE % |
- | - | - | 10.25 | 10.08 | 7.25 | 24.55 | 7.66 | 8.32 | 11.27 | 10.92 | 11.49 | 11.66 |
Current Ratio |
1.9 | 2.0 | 2.1 | 1.8 | 1.9 | 2.2 | 2.3 | 1.1 | 1.0 | 1.4 | 1.2 | 1.2 | 1.0 |
DSO |
- | - | - | - | 0.0 | 0.0 | - | 75.3 | 76.4 | 69.8 | 78.3 | 79.5 | 76.1 |
DIO |
- | - | - | - | - | - | - | 130.3 | 130.6 | 128.2 | 135.3 | 131.2 | 114.0 |
DPO |
- | - | - | - | - | - | - | 101.5 | 118.9 | 114.0 | 114.4 | 108.8 | 95.9 |
Operating Cycle |
- | - | - | - | 0.0 | 0.0 | - | 205.6 | 207.0 | 198.0 | 213.6 | 210.7 | 190.1 |
Cash Conversion Cycle |
- | - | - | - | 0.0 | 0.0 | - | 104.1 | 88.1 | 84.0 | 99.2 | 101.9 | 94.2 |
All numbers in USD currency
Quarterly Financial Ratios Novartis AG
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
- | - | 0.77 | - | - | - | 1.29 | - | - | - | 0.82 | - | - | - | 2.94 | - | - | - | 3.34 | - | - | - | 0.84 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | 1.01 | - | - | - | 1.54 | - | - | - | 1.02 | - | - | - | 1.14 | - | - | - | 1.04 | - | - | - | 0.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
5.38 | 2.69 | 8.04 | 10.70 | 10.70 | 5.35 | 8.81 | 6.93 | 6.93 | 3.46 | 16.67 | 26.41 | 26.41 | 13.20 | 23.30 | 20.20 | 20.20 | 10.10 | 12.93 | 5.66 | 5.66 | 2.83 | 2.83 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
2.76 | 1.38 | 3.71 | 4.67 | 4.67 | 2.33 | 3.84 | 3.02 | 3.02 | 1.51 | 7.36 | 11.69 | 11.69 | 5.85 | 11.32 | 10.94 | 10.94 | 5.47 | 5.47 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
4.68 | 2.34 | 6.02 | 7.37 | 7.37 | 3.69 | 6.18 | 4.98 | 4.98 | 2.49 | 5.58 | 6.18 | 6.18 | 3.09 | 5.22 | 4.26 | 4.26 | 2.13 | 5.39 | 6.52 | 6.52 | 3.26 | 3.26 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
- | - | 2.0 | - | 2.1 | - | 1.8 | - | 1.8 | - | 1.8 | - | 1.9 | - | 1.8 | - | 2.2 | - | 2.2 | - | 2.3 | - | - | - | 2.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency